Cytori Reports Q1 2018 Business and Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. BAC
2. NVDA
3. DPZ
4. ACI
5. ORCL
6. DRS
7. GS
8. JPM
9. AVAV
10. CRWV

Go back to Cytori Reports Q1 2018 Business and Financial Results

Cytori Therapeutics (CYTX) Misses Q1 EPS by 1c

May 10, 2018 4:28 PM EDT

Cytori Therapeutics (NASDAQ: CYTX) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.74 million.

Q1 2018 operating cash burn was $4.1 million, compared to $4.8 million for Q1 2017.

For earnings history and... More